We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: US FDA Cooperation Spurred Inspections Activity in 2010
EMA: US FDA Cooperation Spurred Inspections Activity in 2010
November 17, 2010
The European Medicines Agency (EMA) received 75 percent more requests for good clinical practice and pharmacovigilance inspections than anticipated for the first half of 2010, in part due to better information sharing with the U.S. Food and Drug Administration, the EMA says in a mid-year report.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor